Clinical Trial Update: 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for the PET radiotracer 68Ga-NYM096 aiming to detect clear cell renal cell carcinoma in presurgical patients with renal masses; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• 68Ga-NYM096

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Clear Cell Renal Cell Carcinoma | Phase 2 | Status: ENROLLING_BY_INVITATION